View Financial HealthThis company has been acquiredThe company may no longer be operating, as it has been acquired. Find out why through their latest events.See Latest EventsNeighbourly Pharmacy 배당 및 자사주 매입배당 기준 점검 0/6Neighbourly Pharmacy 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률-0.5%자사주 매입 수익률총 주주 수익률-0.5%미래 배당 수익률0%배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Aug 14Neighbourly Pharmacy Inc. Announces CFO ChangesNeighbourly Pharmacy Inc. announced the appointment of J.P. Arcand as Chief Financial Officer. Mr. Arcand is a seasoned retail finance executive with over 20 years of experience. Mr. Arcand joins Neighbourly from Helly Hansen, a leading designer and retailer of sports apparel owned by Canadian Tire Corporation, where he most recently served as CFO in Norway, overseeing its global operations across 40 countries and multiple channels. At Neighbourly, Mr. Arcand will oversee all aspects of Neighbourly's financial operations, including financial planning and analysis, accounting, and treasury functions. He will work closely with the rest of the executive team to support Neighbourly's long-term growth objectives. Mr. Arcand succeeds Billy Wong who is leaving Neighbourly for another opportunity. Mr. Arcand will be starting at Neighbourly effective August 19, 2024.공시 • Mar 23Neighbourly Pharmacy Inc. COM to Be Deleted from OTC EquityNeighbourly Pharmacy Inc. COM (Canada) will be deleted from OTC Equity effective March 22, 2024, due to Acquisition /Merger /Amalgamation.공시 • Mar 21+ 1 more updateNeighbourly Closes Go-Private Deal with PersistenceNeighbourly Pharmacy Inc. has closed the previously announced plan of arrangement to be taken private by Persistence Capital Partners (PCP). "Today's announcement marks an important milestone for Neighbourly. We are excited for a bright future as a private company," said Skip Bourdo, chief executive officer of Neighbourly. "This going-private transaction provides us with increased flexibility to pursue our growth initiatives, invest in innovation and drive operational excellence. We are focused on continuing to grow our network of pharmacies and serve more communities across Canada." As a result of the transaction, the common shares are expected to be delisted from the Toronto Stock Exchange (TSX) at the close of trading on or about March 21, 2024. The company has submitted an application to cease to be a reporting issuer under applicable Canadian securities laws and to otherwise terminate the company's public reporting requirements.공시 • Jan 23Neighbourly Pharmacy Inc. Announces Executive ChangesNeighbourly Pharmacy Inc. announced the appointment of Maura Dyer as Senior Vice President, People and Culture. Ms. Dyer is a seasoned human resources executive with over 20 years of experience at well-respected Canadian healthcare, telecommunications, and financial services organizations. Her expertise in talent acquisition, employee development, and HR operations will be instrumental in enhancing Neighbourly's reputation as a workplace that attracts and retains top talent. Most recently, Ms. Dyer led several Human Resources functions at Extendicare Inc., a leading provider of care and services for seniors across Canada. At Neighbourly, Ms. Dyer will lead the People and Culture team and will play a critical role in advancing the Company's growth through the development and continuous improvement of a Talent and Culture strategy. Ms. Dyer succeeds Roy Wieschkowski, who has decided to retire from corporate life after five successful years leading the Human Resources and Payroll teams at Neighbourly, supporting the Company's rapid growth and culture evolution. Mr. Wieschkowski's retirement marks the end of an accomplished 38 year-long career, leading Human Resources functions across various industry sectors including pharmaceuticals, retail, chemical and manufacturing. Ms. Dyer joins the Neighbourly team effective February 12, 2024.공시 • Jan 19Neighbourly Pharmacy Inc. to Report Q3, 2024 Results on Feb 13, 2024Neighbourly Pharmacy Inc. announced that they will report Q3, 2024 results at 7:00 AM, US Eastern Standard Time on Feb 13, 2024공시 • Oct 05PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million.PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million on October 3, 2023. As per consideration, the Persistence Capital Partners will pay CAD 20.50 in cash for each share of Neighbourly Pharmacy. The PCP GP secured fully committed debt and equity financing. Devon Park Advisors provided capital raising services to PCP. PCP currently beneficially owns or has control or direction over, directly or indirectly, 22.4 million common shares. The transaction has been unanimously approved by the Neighbourly Pharmacy board of directors. The transaction is subject to a definitive agreement, regulatory, court and/or stock exchange approvals, receiving an updated Fairness Opinion from TD and approval from shareholders of Neighbourly Pharmacy. The transaction is expected to close in the last calendar quarter of 2023 or early in the first calendar quarter of 2024. TD Securities acted as financial and provided fairness opinion to Neighbourly Pharmacy. Scotiabank and RBC Capital Markets acted as financial advisors to PCP. Stikeman Elliott LLP acted as legal advisor to PCP on the transaction. McCarthy Tétrault LLP acted as independent legal advisor to the Transaction Committee.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 NBLY.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: NBLY.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Neighbourly Pharmacy 배당 수익률 vs 시장NBLY.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (NBLY.F)0%시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Consumer Retailing)1.0%분석가 예측 (NBLY.F) (최대 3년)0%주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 NBLY.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 NBLY.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: NBLY.F US 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: NBLY.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/03/20 15:26종가2024/03/20 00:00수익2023/12/30연간 수익2023/03/25데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Neighbourly Pharmacy Inc.는 7명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Kyle McPheeATB Cormark Historical (Cormark Securities)Clarence PowellBMO Capital Markets Equity ResearchChristopher LiDesjardins Securities Inc.4명의 분석가 더 보기
공시 • Aug 14Neighbourly Pharmacy Inc. Announces CFO ChangesNeighbourly Pharmacy Inc. announced the appointment of J.P. Arcand as Chief Financial Officer. Mr. Arcand is a seasoned retail finance executive with over 20 years of experience. Mr. Arcand joins Neighbourly from Helly Hansen, a leading designer and retailer of sports apparel owned by Canadian Tire Corporation, where he most recently served as CFO in Norway, overseeing its global operations across 40 countries and multiple channels. At Neighbourly, Mr. Arcand will oversee all aspects of Neighbourly's financial operations, including financial planning and analysis, accounting, and treasury functions. He will work closely with the rest of the executive team to support Neighbourly's long-term growth objectives. Mr. Arcand succeeds Billy Wong who is leaving Neighbourly for another opportunity. Mr. Arcand will be starting at Neighbourly effective August 19, 2024.
공시 • Mar 23Neighbourly Pharmacy Inc. COM to Be Deleted from OTC EquityNeighbourly Pharmacy Inc. COM (Canada) will be deleted from OTC Equity effective March 22, 2024, due to Acquisition /Merger /Amalgamation.
공시 • Mar 21+ 1 more updateNeighbourly Closes Go-Private Deal with PersistenceNeighbourly Pharmacy Inc. has closed the previously announced plan of arrangement to be taken private by Persistence Capital Partners (PCP). "Today's announcement marks an important milestone for Neighbourly. We are excited for a bright future as a private company," said Skip Bourdo, chief executive officer of Neighbourly. "This going-private transaction provides us with increased flexibility to pursue our growth initiatives, invest in innovation and drive operational excellence. We are focused on continuing to grow our network of pharmacies and serve more communities across Canada." As a result of the transaction, the common shares are expected to be delisted from the Toronto Stock Exchange (TSX) at the close of trading on or about March 21, 2024. The company has submitted an application to cease to be a reporting issuer under applicable Canadian securities laws and to otherwise terminate the company's public reporting requirements.
공시 • Jan 23Neighbourly Pharmacy Inc. Announces Executive ChangesNeighbourly Pharmacy Inc. announced the appointment of Maura Dyer as Senior Vice President, People and Culture. Ms. Dyer is a seasoned human resources executive with over 20 years of experience at well-respected Canadian healthcare, telecommunications, and financial services organizations. Her expertise in talent acquisition, employee development, and HR operations will be instrumental in enhancing Neighbourly's reputation as a workplace that attracts and retains top talent. Most recently, Ms. Dyer led several Human Resources functions at Extendicare Inc., a leading provider of care and services for seniors across Canada. At Neighbourly, Ms. Dyer will lead the People and Culture team and will play a critical role in advancing the Company's growth through the development and continuous improvement of a Talent and Culture strategy. Ms. Dyer succeeds Roy Wieschkowski, who has decided to retire from corporate life after five successful years leading the Human Resources and Payroll teams at Neighbourly, supporting the Company's rapid growth and culture evolution. Mr. Wieschkowski's retirement marks the end of an accomplished 38 year-long career, leading Human Resources functions across various industry sectors including pharmaceuticals, retail, chemical and manufacturing. Ms. Dyer joins the Neighbourly team effective February 12, 2024.
공시 • Jan 19Neighbourly Pharmacy Inc. to Report Q3, 2024 Results on Feb 13, 2024Neighbourly Pharmacy Inc. announced that they will report Q3, 2024 results at 7:00 AM, US Eastern Standard Time on Feb 13, 2024
공시 • Oct 05PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million.PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million on October 3, 2023. As per consideration, the Persistence Capital Partners will pay CAD 20.50 in cash for each share of Neighbourly Pharmacy. The PCP GP secured fully committed debt and equity financing. Devon Park Advisors provided capital raising services to PCP. PCP currently beneficially owns or has control or direction over, directly or indirectly, 22.4 million common shares. The transaction has been unanimously approved by the Neighbourly Pharmacy board of directors. The transaction is subject to a definitive agreement, regulatory, court and/or stock exchange approvals, receiving an updated Fairness Opinion from TD and approval from shareholders of Neighbourly Pharmacy. The transaction is expected to close in the last calendar quarter of 2023 or early in the first calendar quarter of 2024. TD Securities acted as financial and provided fairness opinion to Neighbourly Pharmacy. Scotiabank and RBC Capital Markets acted as financial advisors to PCP. Stikeman Elliott LLP acted as legal advisor to PCP on the transaction. McCarthy Tétrault LLP acted as independent legal advisor to the Transaction Committee.